Topics
October 2014 | Cover Stories
Applications for Neuroprotection: The Next Therapeutic Category in Retina Medicine
Pravin U. Dugel, MD
November/December 2013 | Cover Stories
Enabling Personalized Medicine in the Management of Uveal Melanoma
The value of a repository for tumor biopsy specimens after gene expression profiling.
Thomas M. Aaberg Jr, MD
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar